Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi A couple of weeks ago, journalists rushed to report on previously undisclosed genetic evidence that mammals sold at the Huanan Seafood Wholesale Market in Wuhan, China—possibly raccoon dogs—might have sparked the COVID-19 pandemic. But to the chagrin of the researchers who …
A new drug that can treat human African trypanosomiasis—commonly known as sleeping sickness—with just one dose has shown promise in a clinical trial in the Democratic Republic of the Congo and Guinea. www.science.org/content/article/news-at-a-glance-snags-emissions-monitoring-negotiations-biodiversity-sleeping-sickness? The rare disease is caused by the parasite Trypanosoma brucei gambiense, which is transmitted by the tsetse fly. Left untreated, it is deadly. …
A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC). The trial will evaluate the drug’s safety and its ability to mitigate monkeypox symptoms and prevent serious outcomes, including death. www.nih.gov/news-events/news-releases/monkeypox-treatment-trial-begins-democratic-republic-congo? The National Institute of Allergy …
Clinical trial for monkeypox medication starts in the Democratic Republic of the Congo Read More »
On the 8th of May 2018, another Ebola epidemic was declared by the Government of the Democratic Republic of Congo. Since then, around 54 patients have presented symptoms of hemorrhagic fever with 35 confirmed Ebola cases. There have also been 25 deaths with 12 of them being confirmed as being caused by Ebola. The outbreak …
How the Ebola Outbreak in May 2018 Will Differ From the Past Read More »
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues Africa | All rights reserved.
